Clinical Trial Update: Haploidentical Donor Hematopoietic Stem Cell Transplant in Treating Patients With Hematologic Malignancies [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating haploidentical donor hematopoietic stem cell transplantation in patients with hematologic malignancies was terminated; results have bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Conditions: Malignant Neoplasm | Phase 2 | Status: TERMINATED | Results posted: 2018-01-09